Capital Partners Llc Aisling serves as Executive at Esperion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital Partners Llc Aisling has executed 3 insider transactions totaling $23.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 24, 2015 involved selling 5,743 shares valued at $620.2K.
Capital Partners Llc Aisling currently holds 1,898,851 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Partners Llc Aisling has been a net seller of ESPR stock. They have purchased $0 and sold $23.5M worth of shares.
Capital Partners Llc Aisling's most recent insider trade was on Apr 24, 2015, when they sold 5,743 shares at $108.00 per share.
Get notified when new Form 4 filings are submitted
| $106.10 |
| Discretionary |
| Apr 23, 2015 | ESPR | $16.4M | Sale | 150,000 | $109.10 | Discretionary |